INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Ensign Group, Inc. - ENSG

Pomerantz LLP is investigating claims on behalf of investors of The Ensign Group, Inc. (“Ensign Group” or the “Company”) (NASDAQ: ENSG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Ensign Group and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. On June 8, 2026, Hunterbrook published a short report alleging that Ensign Group’s business model relies on inadequate patient care and gaming quality metrics. The Hunterbrook report further alleges that Ensign Group’s profits depend on understaffing facilities while routing taxpayer dollars to executives and affiliates, and that patients have suffered and died as a result. Following publication of the Hunterbrook report, Ensign Group’s stock price fell $13.88 per share, or 8.15%, to close at $156.42 per share on June 8, 2026. Then, on June 11, 2026, Muddy Waters Research published a short report on Ensign Group, alleging possible Medicare and Medicaid fraud via a scheme to rent licenses of administrators of skilled nursing facilities who are not actually managing the facilities, potentially in violation of the False Claims Act. Following publication of the Muddy Waters report, Ensign’s stock price fell $4.52 per share, or 2.98%, to close at $147.13 per share on June 11, 2026.